Synthetic Peptide
CAZIP Synthetic Peptide, PEP-1026, from Invitrogen.
CAZIP, also known as TIP150, contains a leucine-zipper domain at the C-terminus and has at least three isoforms. CAZIP is expressed in heart during early cardiac development and in parts of the nervous system in later embryonic development. It is thought to bind microtubules and facilitate the end-binding protein 1 (EB1)-dependent loading of MCAK onto microtubules plus ends and orchestrates the dynamics at the plus end of microtubules. CAZIP may regulate the dynamics of microtubules at their growing distal tip.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-176414 |
| Réf. fabricant | 15225029 |
| Gene ID (Entrez) | 23281 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q5JR59 |
| Nom usuel | Human CAZIP |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | MTUS2 |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
